Defence

Financial Planning & Information Services Inc. has $378,000 in UnitedHealth Group Incorporated (NYSE:UNH)


Financial Planning & Information Services Inc. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNHGet a rating) by 8.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736 shares of the healthcare conglomerate’s stock after selling 67 shares during the quarter. As of the latest filing with the SEC, shares of Financial Planning & Information Services Inc. in UnitedHealth Group were worth $378,000.

Several other large investors also recently made changes to their positions in UNH. Signature Estate & Investment Advisors LLC raised its stake in UnitedHealth Group by 1.2% in the first quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock worth $820,000 after buying an additional 19 shares during the period. Steph & Co. raised its stake in UnitedHealth Group by 1.6% in the first quarter. Now Steph & Co. owns 1,290 shares of the healthcare conglomerate’s stock valued at $658,000 after buying an additional 20 shares during the period. First City Capital Management Inc. raised its stake in UnitedHealth Group by 1.5% in the first quarter. First City Capital Management Inc. now owns 1,350 shares of the healthcare conglomerate’s stock valued at $688,000 after buying an additional 20 shares during the period. Harvey Investment Co. LLC raised its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Harvey Investment Co. LLC now owns 4,835 shares of the healthcare conglomerate’s stock valued at $2,483,000 after purchasing an additional 20 shares in the last quarter. Finally, Griffin Asset Management Inc. raised its stake in shares of UnitedHealth Group by 0.3% during the first quarter. Now Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock valued at $3,414,000 after purchasing an additional 21 shares in the last quarter. Institutional investors and hedge funds own 87.25% of the company’s shares.

Changes in analysts’ ratings

Several equities research analysts recently commented on the company. Argus upped their price objective on UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a report on Monday, July 25th. Loop Capital started coverage on UnitedHealth Group in a report on Thursday, June 16th. They set a “buy” rating and a $575.00 price target for the company. Mizuho boosted their target price on UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, August 10th. Morgan Stanley boosted their price target on UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Finally, SVB Leerink upped their target price on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. Three research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $586.40, according to MarketBeat.

Insider buying and selling at UnitedHealth Group

In other news, UnitedHealth Group, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction amounting to $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a filing with the Securities and Exchange Commission, which can be accessed via this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction amounting to $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a filing with the Securities and Exchange Commission, which can be accessed via this link. In addition, the general director Dirk S. McMahon sold 14,715 shares of UnitedHealth Group stock in a transaction on Thursday, August 18th. The shares were sold at an average price of $543.32 for a total value of $7,994,953.80. Following the completion of the sale, the chief executive officer now directly owns 50,108 shares in the company, valued at approximately $27,224,678.56. Disclosures for this sale can be found here here. Insiders have sold 139,051 shares of company stock valued at $74,450,958 over the last 90 days. 0.40% of shares are owned by insiders.

UnitedHealth Group stock performance

NYSE:UNH opened at $505.04 on Friday. The company has a gearing ratio of 0.77, a current ratio of 0.77, and a debt-to-equity ratio of 0.60. The stock has a market cap of $472.40 billion, a P/E ratio of 26.37, a PEG ratio of 1.59 and a beta of 0.76. The company’s 50-day moving average is $528.35, and its 200-day moving average is $513.42. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29.

UnitedHealth Group (NYSE:UNHGet a rating) last issued its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a return on equity of 5.95%. The company’s revenue grew by 12.6% compared to the same period last year. In the same quarter last year, earnings per share amounted to $4.70. Overall, equities analysts forecast that UnitedHealth Group Incorporated will post 21.86 earnings per share for the current fiscal year.

UnitedHealth Group announces dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were paid a dividend of $1.65 per share. This represents an annualized dividend of $6.60 and a yield of 1.31%. The ex-dividend date of this dividend was Friday, September 9th. UnitedHealth Group’s payout ratio is 34.46%.

UnitedHealth Group Company Profile

(Get a rating)

UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It operates in four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health care plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care and wellness services for people age 50 and older that meet their needs for preventive and emergency health care, as well as services related to chronic diseases and other specialized problems for older adults; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)



Get UnitedHealth Group news and ratings daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies MarketBeat.com’s FREE Daily E-Newsletter.

https://www.defenseworld.net/2022/10/01/financial-planning-information-services-inc-has-378000-holdings-in-unitedhealth-group-incorporated-nyseunh.html Financial Planning & Information Services Inc. has $378,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Back to top button